Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
2 clinical trials · Condition
◉ Watch Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (NCT06957691) | Shehzad Basaria, M.D. | 2026-01-14 |
| Effectiveness and Safety of Firmagon® (NCT00930319) | Ferring Pharmaceuticals | 2009-06-01 |
Track Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.